Eight Roads

Our Venture Partner, Mihir Shah deep dives into why #saas vendors must embrace zero-copy data sharing to stay competitive. Zero-copy data sharing is no longer a nice-to-have—it is an essential feature for SaaS vendors looking to retain existing customers and win new ones.   But what is zero-copy data sharing? Read the article below and find out.   Mihir is a Venture Partner with our India Tech team and our U.S based sister fund F-Prime Capital. He’s also an Advisor-in-Residence at Ernest & Young. He recently retired from Fidelity Investments where he was the CIO responsible for ‘All things data’ for the firm. He is currently advising VC’s, Start-ups and large corporations on their Data and Analytics strategy.   #SaaS #EnterpriseDataIntegration #ZeroCopySharing #Technology #Innovation #Startups

2024 Wrap-Up at Eight Roads 🎉 Reflecting on a fantastic year of growth and innovation in Europe, here are some highlights that made our 2024 special ✨ 🤝 Proud to welcome five new companies to our family: Pelago, Eon.io, Directus, Easol and HERO Software 🌟 Celebrated major milestones for our portfolio: Including Neo4j hitting $200M+ revenue, Lighthouse's $370M Series C round 📊 Launched the first European SME Vertical SaaS ranking 🎯 Connected with our community across Europe through 30+ industry events Thank you to everyone who partnered with us this year 🙏 As we look ahead to 2025, we're energized by the talented founders and teams we work with. Here's to another year of building and scaling transformative companies in Europe & Israel 💪 #VentureCapital #Scaleup #TechInvestment #Innovation #2024Highlights #EightRoads

We love ending the week celebrating the wins of our companies, founders and their teams. Today we raise a toast to Enzene Biosciences Ltd for winning the ‘Excellence in BioTech Innovation’ award at the India Pharma Awards 2024 🥇Kudos to the team for continously pushing the boundaries to drive #biotech innovations that enhance patient outcomes. 🌐 Enzene Biosciences is a leading global contract development and manufacturing organization 🧬 They pioneered the continuous bioprocess manufacturing platform – EnzeneX 🏭 Designed for efficiency and cost-effectiveness, EnzeneX™ enables superior product quality and manufacturing outcomes Dr. Himanshu Gadgil #BioTech #Innovation #Healthcare #CDMO #startups

🙌 Huge congratulations to Everstage on being named Customers’ Choice 2024 by Gartner Peer Insights. This is a significant milestone that underscores why you lead the way in sales compensation automation. Cheers Siva Rajamani & Vivek Suriyamoorthy, here’s to even more growth and success! 🚀   #SalesCompensation #GartnerCustomersChoice #SalesOps #Technology #Startups

What’s in store for China healthcare in 2025? This is one of the key issues our Managing Partner and Head of China Jarlon Tsang dived in with Giovanni Amodeo of ION Analytics in a recent interview. As an investment veteran, Jarlon also highlighted his experience of investing in and managing companies through the ups and downs of economic cycles. Check out the full interview: https://bit.ly/3OLlYWv #healthcare #pevc

🚀 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗶𝗻𝗴 𝘁𝗵𝗲 𝗘𝗨 𝗦𝗠𝗘 𝗩𝗲𝗿𝘁𝗶𝗰𝗮𝗹 𝗦𝗮𝗮𝗦 𝟱𝟬 We’re thrilled to partner with āltitude to spotlight Europe’s top 50 SME Vertical SaaS scale-ups—trailblazing companies redefining how Europe’s 26 million SMEs operate. These businesses are the backbone of our economy, employing 100 million people and driving innovation across industries such as hospitality, healthcare, and manufacturing. 𝗞𝗲𝘆 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗹𝗶𝘀𝘁 👇 🏆 Top verticals: Hospitality (24%) and Healthcare (22%). 🌍 Geographical leaders: 30% of companies are based in DACH, with Benelux and Southern Europe close behind at 16% each. 📈 Economic impact: Collectively, these scale-ups have raised $2.6bn in funding and employ over 12,000 people, with an average growth rate of 153% in year two. 🔍 𝗪𝗵𝘆 𝗩𝗲𝗿𝘁𝗶𝗰𝗮𝗹 𝗦𝗮𝗮𝗦 𝗶𝘀 𝗯𝗼𝗼𝗺𝗶𝗻𝗴: 🔹 Generational change: Young leaders are modernizing traditionally "old-school" industries. 🔹 Embedded finance: Payments, lending, and more are now seamlessly integrated into SaaS. 🔹 The digital imperative: SMEs need innovative, user-friendly tools to compete with global giants. Congratulations to the incredible founders and teams behind the EU SME Vertical SaaS 50—we can’t wait to see how you shape the future 🎉 #VerticalSaaS #SMEVertical #SaaS #SMEs #Innovation #DigitalTransformation

🪩Whoop whoop! Blissclub walked away with the ‘Breakout Brand of the Year’ award at CNBC-TV18’s India Business Leader Awards! Big congratulations Minu & the Blissclub team. Here’s to leading the way and building the largest community-first consumer brand to help women #keepmoving. 💃 #awards #blissclub #consumerbrands #community #startups #IBLA

“We are thrilled to re-unite with two of our former partners – Laurus Labs Limited & Laurus Bio (formerly Richcore Lifesciences) who have built a best-in-class biomanufacturing platform to cater to the growing global demand for sustainable manufacturing technologies. Biomanufacturing is already being utilized across a range of industries including personal care, materials, food and nutrition and pharmaceuticals. We are looking forward to growing Laurus Bio into a global leader in this emerging segment.” Prem Pavoor, Managing Partner, Eight Roads Ventures India   Laurus Bio is an integrated research-driven biomanufacturing organization with deep expertise in precision fermentation and recombinant technology. The company will use the funds to expand their fermentation based manufacturing facility, to meet expanding growth opportunities.   Read The Times Of India article to learn more about this partnership: https://lnkd.in/gHU5G-kk   Dr.Satyanarayana Chava, Rajesh Krishnamurthy #biomanufacturing #pharmaceuticals #healthcare #CDMO

⚡ We're delighted to announce that Ze'ev Rozov, former COO of HiBob, has joined Eight Roads as a Venture Partner to support our portfolio across Europe & Israel 💫 Ze'ev brings a stellar track record of scaling companies and extensive experience as both an entrepreneur and operator 🙌 💬 Our Managing Partner Davor Hebel recently sat down with Ze'ev to discuss building businesses, international expansion, and his journey at HiBob. Read more below ⬇️ 🔹𝗪𝗵𝗮𝘁 𝗴𝗿𝗼𝘄𝘁𝗵 𝗹𝗲𝘃𝗲𝗿𝘀 𝗵𝗮𝘃𝗲 𝗯𝗲𝗲𝗻 𝗽𝗶𝘃𝗼𝘁𝗮𝗹 𝗳𝗼𝗿 𝗛𝗶𝗕𝗼𝗯? "A key growth driver as we scaled from $100M ARR and beyond was building an effective partnership ecosystem." This included a comprehensive partnership strategy - encompassing tech, integrations, and channel partners that enabled HiBob to accelerate growth and scale sustainably. 🔹 𝗪𝗵𝗲𝗻 𝘀𝗵𝗼𝘂𝗹𝗱 𝘀𝗰𝗮𝗹𝗲𝘂𝗽 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗽𝘂𝗿𝘀𝘂𝗲 𝗠&𝗔, 𝗮𝗻𝗱 𝘄𝗵𝗲𝗻 𝘀𝗵𝗼𝘂𝗹𝗱 𝘁𝗵𝗲𝘆 𝗮𝘃𝗼𝗶𝗱 𝗶𝘁? M&A can be an incredibly powerful tool if used strategically, Ze'ev explains. It's crucial to have a clear strategy and understand exactly what you aim to achieve - whether it's accelerating growth, entering a new market, or acquiring technology to shorten time-to-market. But don't fall in love with a deal to the point you can't walk away. Integration capability is crucial. For companies embarking on their first deals, the disruption can be significant, so it's essential to ensure you're equipped for seamless execution. 🔹𝗪𝗵𝗲𝗻 𝘀𝗵𝗼𝘂𝗹𝗱 𝘀𝗰𝗮𝗹𝗲𝘂𝗽 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗲𝘅𝗽𝗮𝗻𝗱 𝗶𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹𝗹𝘆, 𝗮𝗻𝗱 𝘄𝗵𝗲𝗻 𝘀𝗵𝗼𝘂𝗹𝗱 𝘁𝗵𝗲𝘆 𝗮𝘃𝗼𝗶𝗱 𝗶𝘁? According to Ze'ev, thinking about international markets from day one is crucial. He notes that for most valuable US tech companies, nearly 50% of their revenue comes from outside the US. However, discipline is critical. Ze'ev advises having a clear and prioritized expansion plan that accounts for market-specific nuances such as regulatory requirements, local infrastructure, and product adjustments. "Be clear about your value proposition and understand what's required to scale effectively in a new market". Welcome to the team, Ze'ev – we're thrilled to have you with us 🎉 #VentureCapital #Team #Scaleup

Enjoyed Ian Hogarth's piece and couldn't agree more that we need our companies to stay independent for longer. As a 20-year European VC "dinosaur" just wanted to offer an optimistic context here: - European technology entrepreneurial ecosystem is about 25 years younger than the US one with first VCs systematically appearing in the US in early 1970s and in mid to late 90s in Europe, so a significant maturity gap is to be expected - Whilst in the early 2000s we started seeing appearance of first billion dollar European companies like Oracle MySQL and Skype that were aquired, by 2010s we have seen the advent of first $10bn+ companies (e.g., Zalando, Spotify, Adyen) that have gone public and stayed indepdendent and now, in 2020s, some of them and the likes of Revolut are on the path of becoming our first $100bn+ homegrown companies - that is major progress - Momentum is building as we have more repeat success role models like Daniel Ek, more experienced managerial talent to help companies scale into $1bn+ of revenue and thousands of employees, and more growth capital than ever before (yes there is still a big gap to the US there but has gotten much better) The ecosystem now can organise itself around some of these huge power-law outcomes. In Eight Roads portfolio alone, we have a number of independent companies like HiBob, Fever, Lighthouse, Owkin, Fireblocks that continue to build global market leadship out of Europe and hopefully many of them will stay independent and remain acquirors rather than acquirees of other signficant companies. Future for Europe is bright and I hope it is trillion dollar bright 😀 🚀